Related Articles
Embracing a New Way of Life After Cancer
After recovering from testicular cancer, I feel as though I’ve earned a second life where I face my fears head-on.
Companies prepare to unveil research at ARVO 2024 conference
More companies have released information on presentations related to their pipelines and new data at the ARVO 2024 conference.
Glenohumeral Superior Translation and Subacromial Contract Pressure Are Both Improved With Superior Capsular Reconstruction: A Systematic Review and Meta-analysis of Biomechanical Investigations
To review cadaveric studies evaluating the biomechanical outcomes of superior capsular reconstruction (SCR) with different graft types for the treatment of irreparable rotator cuff (RTC)…
The Challenging Diagnosis and Long Treatment Journey of CSU, From a Patient Perspective
The pain of chronic spontaneous urticaria (CSU) can be crippling, explained Kristen Willard, a patient advocate with CSU, who discussed her treatment journey.
NYC parents call for AI-themed high school to prep kids for future of…
Five parent members of the Citywide Council on High Schools co-sponsored a resolution recommending a specialized school that would integrate AI into the core subjects.
How Mass General Brigham’s Anne Klibanski fights capacity issues
CEO Dr. Anne Klibanski spoke candidly about Mass General Brigham’s capacity issues, including what is driving them and what the system is doing in response.
Digital health startup Transcarent valued at $2.2 bln after latest funding round – ET HealthWorld
General Catalyst: Transcarent, which was founded in 2020, helps companies to cut costs and effectively manage health care benefits for their employees by reducing complexity.…
Houthis offer education to students suspended in US protest crackdown
Yemen’s Iran-aligned Houthi militia, which has disrupted global shipping to display its support for Palestinians in the Gaza conflict, is now offering a place for…
CCTG HN13 study awarded funding in the Spring 2023 CIHR competition | Canadian Cancer Trials Group
CCTG HN13 clinical trial has successfully been awarded $1,602,675 in the Spring 2023 CIHR funding competition to investigate improving head and neck tumour and symptom…
Xolremdi Approved for Patients With WHIM Syndrome
The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 4WHILM trial.